GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regenerative Medical Technology Group Inc (OTCPK:RMTG) » Definitions » Net Interest Income

RMTG (Regenerative Medical Technology Group) Net Interest Income : $-6.26 Mil (TTM As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is Regenerative Medical Technology Group Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Regenerative Medical Technology Group's net interest income for the three months ended in Sep. 2024 was $-0.91 Mil. Its net interest income for the trailing twelve months (TTM) ended in Sep. 2024 was $-6.26 Mil.


Regenerative Medical Technology Group Net Interest Income Historical Data

The historical data trend for Regenerative Medical Technology Group's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regenerative Medical Technology Group Net Interest Income Chart

Regenerative Medical Technology Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Interest Income
Get a 7-Day Free Trial -0.57 -4.20 -2.72 -4.40 -6.49

Regenerative Medical Technology Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.66 -1.63 -1.85 -1.86 -0.91

Regenerative Medical Technology Group Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Regenerative Medical Technology Group Net Interest Income Related Terms

Thank you for viewing the detailed overview of Regenerative Medical Technology Group's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Regenerative Medical Technology Group Business Description

Traded in Other Exchanges
N/A
Address
433 Plaza Real, Suite 275, Boca Raton, FL, USA, 33432
Regenerative Medical Technology Group Inc operates through its subsidiary. Its focus has been mainly dedicated to its operations serving the markets in the regenerative medicine industry. It believes stem cell therapy is becoming an increasingly effective clinical solution for treating conditions that traditional or conventional medicine only offers within palliative care and pain management. Patients around the world are seeking a natural regenerative alternative without the potential risks and side effects sometimes associated with conventional pharmaceuticals.
Executives
Benito Novas 10 percent owner 433 PLAZA REAL, SUITE 275, BOCA RATON FL 33432
David Eugene Christensen director, 10 percent owner, officer: President and CEO 433 PLAZA REAL, SUITE 275, BOCA RATON FL 33432
Pereira Melvin Antonio Loria director, 10 percent owner, officer: CEO, Chairman RESIDENCIAL HACIENDA EL GREGAL, #24-1 SANCHEZ, CURRIDABAT, SAN JOSE G2 11803

Regenerative Medical Technology Group Headlines

From GuruFocus

Meso Numismatics and Global Stem Cell Group Expand its Global Footprint

By GuruFocusNews GuruFocusNews 06-27-2022

Meso Numismatics Becomes Fully Reporting Company

By Marketwired Marketwired 02-13-2019

Meso Numismatics Files 10K with Securities and Exchange Commission

By Marketwired Marketwired 04-18-2019

Meso Numismatics Provides Update On Global Stem Cell Transaction

By Marketwired Marketwired 05-19-2020

Meso Numismatics Closes Global Stem Cell Group Acquisition

By Marketwired Marketwired 08-19-2021

Meso Numismatics and Global Stem Cell Group Expand its Global Footprint

By GuruFocusNews GuruFocusNews 07-07-2022

Meso Numismatics Files Application to Upgrade to OTCQB

By Marketwired Marketwired 03-12-2019